Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility

被引：0
|
作者：
Samaras, K.
Wand, H.
Law, M.
Emery, S.
Cooper, D. A.
Carr, A.
机构：
[1] Garvan Inst Med Res, Sydney, NSW, Australia
[2] Univ New S Wales, Natl Ctr HIV Epidemiol, Clin Res, Kensington, NSW 2033, Australia
[3] St Vincent Hosp, Sydney, NSW, Australia
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L4 / L4
页数：1
相关论文
共 50 条
  • [1] PREDICTION OF DIABETES AND CARDIOVASCULAR EVENTS IN HIV INFECTED PATIENTS WITH METABOLIC SYNDROME DEFINED BY ATPIII AND IDF CRITERIA
    Ena, J.
    Benito, C.
    Amador, C.
    Selles, I.
    de Apodaca, R. Ruiz
    Pasquau, F.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 128 - 128
  • [2] Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population
    Hajat, Cother
    Shather, Zainab
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (03) : 481 - 486
  • [3] Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals
    Nakazone, Marcelo Arruda
    Pinheiro, Anielli
    Vauria Braga Braile, Maria Christiane
    De Souza Pinhel, Marcela Augusta
    De Sousa, Gisele Firmino
    Pinheiro, Sidney, Jr.
    Brandao, Antonio Carlos
    Yugar Toledo, Juan Carlos
    Braile, Domingo Marcolino
    Silva Souza, Doroteia Rossi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2007, 53 (05): : 407 - 413
  • [4] METABOLIC SYNDROME PREVALENCE AND POPULATION ATTRIBUTABLE RISK AMONG HIV/AIDS PATIENTS: COMPARISONS BETWEEN NCEP-ATPIII, IDF AND AHA/NHLBI CRITERIA
    de Alencastro, P. R.
    Fuchs, S. C.
    de Oliveira, R. R.
    Holff, F. H.
    Ikeda, M. L. R.
    Brandao, A. B. M.
    Barcellos, N. T.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A444 - A444
  • [5] Prevalence of overweight, obesity and metabolic syndrome in HIV-infected patients
    Rebeca Antunes Beraldo
    Giovanna Soler Donofre
    Anderson Maliere Navarro
    Valdes Roberto Bollela
    Andre Schmidt
    Maria Cristina Foss-Freitas
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [6] Prevalence of metabolic syndrome (MS) among HIV-infected patients
    Jericó, C
    Knobel, H
    Montero, M
    Sorli, M
    López-Colomés, J
    Pedro-Botet, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 53 - 53
  • [7] Influence of Criteria Used in Determining Prevalence of Metabolic Syndrome (NCEP-ATPIII versus IDF) in Patients with Intermittent Claudication
    Zerati, Antonio Eduardo
    Monteiro Guimaraes, Ana Lucia
    Miranda de Carvalho, Heitor Andrei
    Saes, Glauco Fernandes
    Ragazzo, Luciana
    Wolosker, Nelson
    de Luccia, Nelson
    ANNALS OF VASCULAR SURGERY, 2014, 28 (03) : 640 - 643
  • [8] Prevalence of Premorbid Metabolic Syndrome in Spanish Adult Workers Using IDF and ATPIII Diagnostic Criteria: Relationship with Cardiovascular Risk Factors
    Tauler, Pedro
    Bennasar-Veny, Miquel
    Morales-Asencio, Jose M.
    Lopez-Gonzalez, Angel A.
    Vicente-Herrero, Teofila
    De Pedro-Gomez, Joan
    Royo, Vanessa
    Pericas-Beltran, Jordi
    Aguilo, Antoni
    PLOS ONE, 2014, 9 (02):
  • [9] Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients
    Paula Freitas
    Davide Carvalho
    Selma Souto
    Ana Cristina Santos
    Sandra Xerinda
    Rui Marques
    Esteban Martinez
    António Sarmento
    José Luís Medina
    BMC Infectious Diseases, 11
  • [10] Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients
    Freitas, Paula
    Carvalho, Davide
    Souto, Selma
    Santos, Ana Cristina
    Xerinda, Sandra
    Marques, Rui
    Martinez, Esteban
    Sarmento, Antonio
    Medina, Jose Luis
    BMC INFECTIOUS DISEASES, 2011, 11
12345